Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Payables (2020 - 2023)

Terns Pharmaceuticals' Payables history spans 4 years, with the latest figure at $3.3 million for Q3 2023.

  • For Q3 2023, Payables rose 58.79% year-over-year to $3.3 million; the TTM value through Sep 2023 reached $3.3 million, up 58.79%, while the annual FY2022 figure was $1.6 million, 22.62% down from the prior year.
  • Payables reached $3.3 million in Q3 2023 per TERN's latest filing, down from $5.5 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $5.5 million in Q2 2023 to a low of $935000.0 in Q4 2020.
  • Average Payables over 4 years is $2.4 million, with a median of $1.9 million recorded in 2021.
  • Peak YoY movement for Payables: crashed 60.52% in 2022, then soared 469.06% in 2023.
  • A 4-year view of Payables shows it stood at $935000.0 in 2020, then soared by 127.38% to $2.1 million in 2021, then decreased by 22.62% to $1.6 million in 2022, then skyrocketed by 102.13% to $3.3 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Payables are $3.3 million (Q3 2023), $5.5 million (Q2 2023), and $2.7 million (Q1 2023).